Clover Health Investments (CLOV) Insider Trading & Ownership $2.72 +0.13 (+4.83%) As of 01:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Clover Health Investments (NASDAQ:CLOV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.07%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$68.64KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$1.89M Get CLOV Insider Trade Alerts Want to know when executives and insiders are buying or selling Clover Health Investments stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Insider Buying and Selling by Quarter Clover Health Investments Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/13/2025Anna U LoengardDirectorBuy26,500$2.59$68,635.00 7/23/2025Conrad WaiCEOSell91,197$3.32$302,774.04 7/22/2025Conrad WaiCEOSell118,600$3.29$390,194.00 3/7/2025Carladenise Armbrister EdwardsDirectorSell200,000$3.61$722,000.00 3/6/2025Brady Patrick PriestCEOSell75,000$3.68$276,000.00 3/6/2025Karen SoaresGeneral CounselSell52,500$3.80$199,500.00 (Data available from 1/1/2013 forward) CLOV Insider Trading Activity - Frequently Asked Questions Who is on Clover Health Investments' Insider Roster? The list of insiders at Clover Health Investments includes Anna U Loengard, Brady Patrick Priest, Carladenise Armbrister Edwards, Conrad Wai, and Karen Soares. Learn more on insiders at CLOV. What percentage of Clover Health Investments stock is owned by insiders? 24.07% of Clover Health Investments stock is owned by insiders. Learn more on CLOV's insider holdings. Which Clover Health Investments insiders have been buying company stock? The following insider purchased CLOV shares in the last 24 months: Anna U Loengard ($185,046.60). How much insider buying is happening at Clover Health Investments? Insiders have purchased a total of 180,585 CLOV shares in the last 24 months for a total of $185,046.60 bought. Which Clover Health Investments insiders have been selling company stock? The following insiders have sold CLOV shares in the last 24 months: Brady Patrick Priest ($276,000.00), Carladenise Armbrister Edwards ($722,000.00), Conrad Wai ($692,968.04), and Karen Soares ($199,500.00). How much insider selling is happening at Clover Health Investments? Insiders have sold a total of 537,297 Clover Health Investments shares in the last 24 months for a total of $1,890,468.04 sold. Clover Health Investments Key ExecutivesMr. Vivek Garipalli (Age 45)Co-Founder & Executive Chairman Mr. Andrew Toy (Age 45)Co-Founder, CEO & Director Compensation: $1.11MMs. Karen Soares (Age 46)General Counsel, Senior VP & Corporate Secretary Compensation: $513.2kMr. Brady Priest J.D. (Age 47)Chief Executive Officer of Home Care Compensation: $647.91kMs. Jamie L. Reynoso (Age 54)Chief Executive Officer of Medicare Advantage Compensation: $705.58kMr. Peter J. Kuipers (Age 52)Chief Financial Officer Mr. Conrad Wai (Age 43)Chief Technology Officer 2 recent tradesMr. Derrick L. NuemanHead of Investor Relations & Corporate strategyMs. Wendy RicheyChief Compliance OfficerMs. Rachel FishChief People Officer More Insider Trading Tools from MarketBeat Related Companies Essent Group Insider Trades Oscar Health Insider Trades F&G Annuities & Life Insider Trades Lemonade Insider Trades Hagerty Insider Trades Alignment Healthcare Insider Trades Baldwin Insurance Group Insider Trades Brighthouse Financial Insider Trades Palomar Insider Trades NMI Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges3 Small Caps That Insiders Are Buying $100 Million Buyback in Upwork Stock Follows a Strong Quarter This page (NASDAQ:CLOV) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
